When ER stress-regulated proteins in the blood were studied as potential biomarkers for PD, it was found that MANF together with three other proteins, PDIA1, PDIA3, and clusterin in combination with age and gender confounders were able to discriminate PD patients from the non-PD group (165). This evidence concerns the gene CLU and Parkinson disease.